Skip to main content
. 2021 Dec 2;2021:3847347. doi: 10.1155/2021/3847347

Table 1.

Distribution of MRSA and VRSA isolates.

Organism/distribution Growth positive, n (%) Gram positive, n (%) S. aureus, n (%) MRSA, n (%) VRSA, n (%)
Sex
 Male (n = 409) 215 (52.6) 93 (43.2) 42 (19.5) 29 (69.0) 3 (10.3)
 Female (n = 386) 149 (38.6) 61 (40.9) 32 (21.5) 16 (50.0) 2 (12.5)
Clinical samples
 Urine (n = 279) 135 (48.3) 32 (23.7) 10 (7.4) 3 (50.0) 0
 Sputum (n = 126) 61 (48.4) 29 (47.5) 13 (21.3) 5 (38.5) 0
 Blood (n = 118) 20 (16.9) 7 (35.0) 6 (30.0) 2 (33.3) 0
 Pus (n = 109) 54 (49.5) 34 (62.9) 16 (29.6) 14 (87.5) 3 (21.4)
 Wound swab (n = 92) 57 (61.9) 42 (73.7) 27 (47.4) 21 (77.8) 2 (9.5)
Others (n = 71) 17 (23.9) 10 (58.8) 2 (11.8) 0 0
Hospital units
 General ward (n = 370) 160 (43.2) 66 (41.3) 32 (20.0) 20 (62.5) 2 (10.0)
 OPD (n = 171) 91 (53.2) 35 (38.5) 15 (16.5) 9 (60.0) 1 (11.1)
 ICU (n = 125) 65 (52.0) 31 (47.6) 17 (26.2) 12 (70.5) 2 (16.7)
 Gynae (n = 129) 48 (37.2) 22 (45.8) 10 (20.8) 4 (40.0) 0
Total (n=795) 364 (45.8) 154 (42.3) 74 (20.3) 45 (60.8) 5 (11.1)

Abbreviations: MRSA = methicillin-resistant Staphylococcus aureus; VRSA = vancomycin-resistant Staphylococcus aureus; others = throat swab, vaginal swab, synovial fluid, and pleural fluid; percentage calculated on respective row total.